Alstonia Healthcare

Rabezo-DSR

Rabezo-DSR is a powerful pharmaceutical combination formulated to effectively combat hyperacidity and gastroesophageal reflux disease (GERD). Each capsule contains Rabeprazole (ER) 20mg and Domperidone (SR) 30mg, working together to neutralize excess stomach acid and support healthy digestive motility.

Key Ingredients

  • Rabeprazole (ER) 20mg: Rabeprazole is a proton pump inhibitor (PPI) engineered to block the production of stomach acid, providing a longer duration of acid inhibition compared to standard treatments. This robust acid suppression helps prevent both daytime and nighttime heartburn, delivering round-the-clock comfort. Additionally, Rabeprazole demonstrates excellent compatibility with antacids and does not exhibit negative interactions when used alongside them, making it suitable for combination therapy in severe acid reflux cases.​

  • Domperidone (SR) 30mg: Domperidone is a well-established prokinetic agent that restores healthy peristalsis—the natural movement of the digestive tract—to control gastric reflux and prevent regurgitation. By improving gastric motility and accelerating gastric emptying, Domperidone helps relieve symptoms of bloating, fullness, and discomfort. Its actions not only curb reflux but also support complete digestion, benefiting patients with sluggish or impaired digestive function.​

Therapeutic Benefits

Rabezo-DSR delivers comprehensive benefits for upper gastrointestinal health:

  • Effective & Extended Acid Control: With Rabeprazole’s prolonged acid inhibition, patients experience reduced acid exposure and heartburn episodes, leading to greater relief from gastric irritation and ulcer risk.

  • Digestive Motility Support: Domperidone enhances gastric emptying and motility, which is critical in preventing reflux esophagitis, and aids in the management of symptoms like nausea and dyspepsia.

  • Synergistic Action: The combined effect of acid suppression and prokinetic activity results in faster and more complete relief from GERD and related symptoms.​

Indications

Rabezo-DSR is indicated for a range of acid-peptic and reflux-related disorders, including:

  • GERD (Gastroesophageal Reflux Disease)

  • Hyperacidity

  • Acid peptic ulcers

  • Dyspepsia

  • Gastritis

  • Reflux esophagitis​

Application

Capsules are best taken as prescribed by a healthcare professional to maximize acid suppression, relieve heartburn, and aid in digestive comfort. The extended-release formulation ensures sustained action, making Rabezo-DSR a preferred choice for both acute and chronic gastric conditions.

Summary

Rabezo-DSR stands out as a powerful dual-action therapy for patients suffering from hyperacidity, GERD, and associated gastric discomfort. By blending Rabeprazole’s potent acid suppression with Domperidone’s digestive motility benefits, this product delivers lasting relief, supports healthy stomach function, and protects against gastric mucosal injury.

Home
About Us
Mail
Free Enquiry
Scroll to Top

Free Enquiry Form